Carta Healthcare closes series B, triples revenue, and brings in seasoned health tech leader Brent Dover to accelerate growth.
Health tech company Carta Healthcare®, whose mission is to harness the value of clinical data, is pleased to announce the appointment of Brent Dover as chief executive officer. Dover succeeds former CEO Matt Hollingsworth who co-founded Carta Healthcare in 2017 and who remains a member of the board. In his new role, he will continue to focus on product innovation, business development, and strategic partnerships for Carta Healthcare’s market-leading solutions.
“I am thrilled to welcome Brent to the Carta Healthcare leadership team. While his expertise in scaling health tech companies is impressive, what stands out most is Brent’s authentic dedication to our mission and his confidence in what we will be able to achieve together,” said Hollingsworth.
Dover brings to Carta Healthcare a wealth of leadership experience in emerging companies with a focus on data-driven healthcare solutions. Over the past two decades, Dover was instrumental in leading several companies through rapid growth trajectories, joining each at pivotal growth stages. Dover most recently served as CEO at Kalderos (2022-2023), CEO at Commure (2019-2021), which in 2021 reached a $3.5 billion valuation, president of Health Catalyst (2013-2018), now a publicly traded healthcare analytics company (NASDAQ:HCAT), and president of Medicity (2007-2012), which sold to Aetna in 2011.
“I am thrilled to join Matt at this critical juncture of Carta Healthcare’s journey. From the very first encounter with the team, their unwavering passion for assisting healthcare professionals and harnessing the power of real-time clinical data left an indelible impression on me. They have built an impressive company, and their strategy is working,” said Dover.
2023 has been a year of substantial growth for Carta Healthcare, achieving a threefold increase in revenue while expanding its healthcare system customers by 50%. In addition to its rapid expansion this year, Carta Healthcare expanded its product offerings and enjoyed its fourth consecutive year of 100% customer retention. The $25 million series B funding round in March of 2023 was used in part to scale operations, enhance and expand the company’s products, hire key team members necessary for the company’s growth, and strengthen the company’s technological infrastructure. This October, Carta Healthcare received the Health Care of the Future Innovation Award from the Portland Business Journal.
Source: Carta Healthcare
